Schizophrenia Research

Schizophrenia is a chronic, debilitating mental disorder affecting 1-2% of the global population. Symptoms are split into two types; 'positive' symptoms, including delusions and hallucinations, and 'negative' symptoms, including anhedonia and lack of motivation. Studies suggest that genetics, early environment, neurobiology, psychological and social processes are important contributory factors; some recreational and prescription drugs appear to cause or worsen symptoms. Several neurobiological alterations in brain structure, physiology and neurochemistry have been documented, along with an ever-increasing list of susceptibility genes.

Schizophrenia Research Products Targets

Products for Schizophrenia Research - Page 19

  1. Cat.No. Product Name Information/Activity
  2. BCC7024 AF-DX 384 118290-26-9 AF-DX 384 chemical structure
  3. BCC7314 AQ-RA 741 Selective, high affinity M<sub>2</sub> antagonist AQ-RA 741 chemical structure
  4. BCC7061 (S)-(+)-Dimethindene maleate 136152-65-3 (S)-(+)-Dimethindene maleate chemical structure
  5. BCC6661 4-DAMP 1952-15-4 4-DAMP chemical structure
  6. BCC7263 DAU 5884 hydrochloride 131780-48-8 DAU 5884 hydrochloride chemical structure
  7. BCC7389 J 104129 fumarate 257603-40-0 J 104129 fumarate chemical structure
  8. BCC7418 Zamifenacin fumarate Zamifenacin fumarate (UK-76654 fumarate) is a potent gut-selective muscarinic M3 receptor antagonist. Zamifenacin significantly reduces colonic motility in irritable bowel syndrome. Zamifenacin fumarate chemical structure
  9. BCC7145 PD 102807 23062-91-1 PD 102807 chemical structure
  10. BCC4574 Tropicamide Tropicamide is an anticholinergic and a muscarinic receptor subtype M4-preferring antagonist . Tropicamide chemical structure
  11. BCC4053 VU0152100 VU0152100 is a potent and selective allosteric potentiator of M4 mAChR with an EC50 of 380 ± 93 nM. VU0152100 chemical structure

Items 181 to 190 of 709 total